BiomX Inc.
PHGE
$4.98
-$0.06-1.19%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -20.60% | 25.13% | 46.54% | 55.89% | 54.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.03% | 5.34% | 22.30% | 47.96% | 40.25% |
| Operating Income | 13.03% | -5.34% | -22.30% | -47.96% | -40.25% |
| Income Before Tax | -104.31% | -329.79% | 29.25% | 78.31% | 32.25% |
| Income Tax Expenses | -46.15% | -18.18% | -68.42% | -59.09% | -43.48% |
| Earnings from Continuing Operations | -104.20% | -329.35% | 29.28% | 78.30% | 32.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -104.20% | -329.35% | 29.28% | 78.30% | 32.26% |
| EBIT | 13.03% | -5.34% | -22.30% | -47.96% | -40.25% |
| EBITDA | 17.04% | -0.27% | -20.28% | -45.86% | -37.88% |
| EPS Basic | 33.90% | 29.66% | 77.11% | 102.10% | 67.49% |
| Normalized Basic EPS | 52.79% | 59.38% | 97.53% | 107.29% | 65.29% |
| EPS Diluted | 73.55% | 67.22% | 85.36% | 55.42% | 18.80% |
| Normalized Diluted EPS | 57.09% | 62.17% | 97.63% | 104.20% | 61.81% |
| Average Basic Shares Outstanding | 133.11% | 203.83% | 267.44% | 197.58% | 159.07% |
| Average Diluted Shares Outstanding | 103.19% | 149.48% | 181.44% | 230.85% | 197.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |